Navigation Links
Crisis Exemption Granted to Market Avipel(R) Corn Seed Treatment in Louisiana
Date:2/27/2009

NEW CASTLE, Del., Feb. 27 /PRNewswire/ -- Arkion(R) Life Sciences has received a Section 18 Crisis Exemption to market Avipel(R) Corn Seed Treatment in Louisiana effective March 1, 2009. The EPA approval means that Louisiana farmers can use Avipel(R) to protect field and sweet corn from marauding blackbirds and grackles for the 2009 planting season. Formerly known as Avitec, Avipel(R) is applied to corn seed before planting and effectively stops birds from damaging crops by eating the newly planted seeds.

This is the first year Avipel(R) has received approval in Louisiana. The product is non-lethal to birds and has been shown to be highly effective in protecting corn seed from birds in over four years of use in states with particular bird problems such as Mississippi, Michigan, Minnesota, South Dakota and Wisconsin. Information about approved uses and labels may be found at the Arkion(R) Life Sciences web site: www.ArkionLS.com.

According to Ken Ballinger (VP, Airepel(R)), Arkion(R) Life Sciences has been a pioneer in the development and commercialization of several formulations of bird repellent and bird management technologies. Arkion's patented formulations of anthraquinone have been effectively repelling geese with FlightControl(R) Plus and repelling birds from structures through the Airepel(R) Humane Bird Management business.

Arkion(R) Life Sciences LLC, based in New Castle, Delaware, is a technology-based company leading in the discovery, development and marketing of environmentally friendly, natural or nature identical bioactive compounds. The company has over 500 patents and patent applications worldwide around these technologies, including the area of feed preservation with N-Sure(R), and employs biotechnology to capitalize on new opportunities in the nutraceutical, pharmaceutical, animal health and agricultural markets. Arkion(R) has three major businesses: Airepel(R), supplying bird repellents which feature a non-lethal method to control where birds feed and roost; Hyperimmune eggs with markets in human and animal nutrition; and Bio-Technical Resources (Manitowoc, WI) which develops processes and products based upon fermentation technology such as glucosamine, N-acetylglucosamine and natamycin.


'/>"/>
SOURCE Arkion Life Sciences
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Crisis Management PR Firms Advice to Stem Cell Agency Laundered Through Law Firm to Avoid Scrutiny
2. Countering an approaching water crisis
3. In the Midst of International Economic Crisis, VidaCura Offers a Helping Hand to Those Without Insurance
4. Life Science Labs Reacting to the Economic Crisis
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. Pharmions Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
7. PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
8. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkins Lymphoma
9. ISTO Technologies Granted Key Patent for Cartilage Cell Expansion by the United States Patent Office
10. Odyssey Thera Granted U.S. Patent for Animal Imaging
11. Mpex Candidate, MP-376, Granted U.S. Orphan Drug Status for the Treatment of Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... -RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) ("RepliCel" ... clinical data from its phase 1/2 tendon repair study investigating ... (RCT-01) as a treatment for Achilles tendinosis. ... The clinical trial ... 6 months and showed no serious adverse events related to ...
(Date:3/28/2017)... ... 28, 2017 , ... Executive search firm, Slone Partners, announces ... Harvill is a distinguished life sciences expert with a proven track record in ... a wide range of services related to laboratory testing and analysis for the ...
(Date:3/27/2017)... ... March 27, 2017 , ... IsoPlexis Corporation (IsoPlexis), a ... disease and more through a single-cell precision engineering platform, today announced it has ... in the laboratory of Dr. James Heath at the California Institute of ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... cancer (mCRC) generally produce small, heterogeneous samples with limited tumor content in a ... remain to be resolved, such as the need for reliable detection of low ...
Breaking Biology Technology:
(Date:3/2/2017)... , March 2, 2017 Who risk to ... Download the full report: https://www.reportbuyer.com/product/4313699/ ... FINGERPRINT SENSOR FIELD? Fingerprint sensors using capacitive technology ... fingerprint sensor vendor Idex forecasts an increase of 360% ... devices and of the fingerprint sensor market between 2014 ...
(Date:2/28/2017)... 28, 2017 News solutions for biometrics, bag ... ... from 14 to 16 March, Materna will present its complete ... seamless travel is a real benefit for passengers. To accelerate ... their passenger touch point solutions to take passengers through the complete ...
(Date:2/24/2017)...  EyeLock LLC, a leader of iris-based identity ... biometric solution on the latest Qualcomm® Snapdragon™ 835 ... World Congress 2017 (February 27 – March ... 3, Stand 3E10. The Snapdragon ... platform—a combination of hardware, software and biometrics ...
Breaking Biology News(10 mins):